Scholar Rock Holding SRRK
NASDAQ SRRK
$55.33 -0.61 (-1.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Scholar Rock Holding (SRRK) Change in Cash (2017 - 2026)

Scholar Rock Holding (SRRK) posted quarterly Change in Cash of $106.4 million for Q1 2026, up 366.19% year-over-year from $22.8 million in Q1 2025, and up 189.32% quarter-over-quarter from $36.8 million in Q4 2025.

Analysis

Scholar Rock Holding (SRRK) Change in Cash (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Change in Cash history runs 10 years deep, the most recent figure standing at $106.4 million for Q1 2026.

  • In Q1 2026, Change in Cash rose 366.19% year-over-year to $106.4 million; the TTM figure through Mar 2026 stood at $293.4 million (up 538.46% YoY), while the FY2025 annual figure was $147.1 million, up 93.43% from the prior year.
  • Change in Cash for Q1 2026 stood at $106.4 million, up from $36.8 million in the prior quarter.
  • The five-year high for Change in Cash was $205.6 million in Q2 2022, with the low at -$172.7 million in Q3 2022.
  • The 5-year median for Change in Cash is $1.4 million (2024), against an average of $12.8 million.
  • The sharpest annual moves came in 2022 and 2025: Change in Cash slumped 8912.8% in 2022, then soared 976.74% in 2025.
  • Scholar Rock Holding's Change in Cash stood at -$29.8 million in 2022, then soared by 214.27% to $34.1 million in 2023, then jumped by 198.04% to $101.5 million in 2024, then sank by 63.78% to $36.8 million in 2025, then soared by 189.32% to $106.4 million in 2026.
  • Business Quant data shows SRRK's Change in Cash at $106.4 million in Q1 2026, $36.8 million in Q4 2025, and $135.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 Scholar Rock Holding 7.24 Bn 7.24 Bn - 7.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.31 Mn
Mar 31, 2026 106.35 Mn
Dec 31, 2025 36.76 Mn
Sep 30, 2025 135.25 Mn
Jun 30, 2025 15.00 Mn
Mar 31, 2025 -39.95 Mn
Dec 31, 2024 101.49 Mn
Sep 30, 2024 -16.98 Mn
Jun 30, 2024 1.39 Mn
Mar 31, 2024 -9.88 Mn
Dec 31, 2023 34.05 Mn
Sep 30, 2023 -40.47 Mn
Jun 30, 2023 -43.10 Mn
Mar 31, 2023 48.01 Mn
Dec 31, 2022 -29.80 Mn
Sep 30, 2022 -172.66 Mn
Jun 30, 2022 205.56 Mn
Mar 31, 2022 -112.66 Mn
Dec 31, 2021 36.70 Mn
Sep 30, 2021 -30.79 Mn